The IMPACT Collaboratory had a strong presence at the 2022 Alzheimer’s Association International Conference, held July 30-August 4, in San Diego, CA.
Members of the IMPACT Administration Core led a pre-conference workshop on July 29th designed to share key considerations in the design and conduct of embedded pragmatic clinical trials for persons living with dementia. IMPACT members who organized and led the workshop included Jill Harrison, PhD, Vincent Mor, PhD, Partha Bhattacharyya, PhD, Marcel Salive, MD, MPH, Kenneth Hepburn, PhD, María Aranda, PhD, MSW, MPA, LCSW, Ellen McCreedy, PhD, MPH, David Reuben, MD, Deborah Barnes, PhD, MPH, and Joseph Gaugler, PhD.
Peggye Dilworth-Anderson, PhD, a member of IMPACT’s Executive Committee and Health Equity Team, received the Bengt Winblad Lifetime Achievement Award in Alzheimer's Disease Research at the conference. The award recognizes a senior investigator whose contributions have shown a lasting impact on the field and whose body of work has demonstrated a career-long commitment towards progress against Alzheimer's and dementia.
IMPACT member presentations included:
Katie Brandt, MM, presented, "Courage in Care Planning: Advance Care Planning Readiness in the Context of COVID-19 for Caregivers of Individuals Living with Dementia"
Emily Largent, PhD, JD, RN, presented, "Participant First: Improving Communication with and Support for Participants in Trials that End Early"
Susan Mitchell, MD, MPH, presented, "Using Embedded Pragmatic Clinical Trials to Improve Dementia Care"
Vince Mor, PhD, presented, “NIA AD/ADRD IMPACT Collaboratory: Expanding Pragmatic Trials in Health Systems”
Brent P. Forester, MD, MSc, co-authored three abstracts:
- Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer’s Disease (THC-AD)
- Identifying delirium in advanced dementia in the ECT-AD clinical trial
- Projection in Proxy Assessments of Everyday Preferences for Persons with Cognitive Impairment